Does TRANDOLAPRIL Cause Interstitial lung disease? 9 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Interstitial lung disease have been filed in association with TRANDOLAPRIL (Trandolapril). This represents 1.5% of all adverse event reports for TRANDOLAPRIL.
9
Reports of Interstitial lung disease with TRANDOLAPRIL
1.5%
of all TRANDOLAPRIL reports
1
Deaths
0
Hospitalizations
How Dangerous Is Interstitial lung disease From TRANDOLAPRIL?
Of the 9 reports, 1 (11.1%) resulted in death.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRANDOLAPRIL. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does TRANDOLAPRIL Cause?
Dyspnoea (87)
Psychotic disorder (81)
Cough (76)
Fatigue (60)
Pneumonia (58)
Hypertension (57)
Asthma (56)
Hypotension (48)
Hallucination, auditory (46)
Paranoia (46)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which TRANDOLAPRIL Alternatives Have Lower Interstitial lung disease Risk?
TRANDOLAPRIL vs TRANDOLAPRIL\VERAPAMIL
TRANDOLAPRIL vs TRANEXAMIC ACID
TRANDOLAPRIL vs TRANYLCYPROMINE
TRANDOLAPRIL vs TRASTUZUMAB
TRANDOLAPRIL vs TRASTUZUMAB-ANNS